Anti-ENTPD2 Antibody

A cell-surface ectonucleotidase that hydrolyzes extracellular ATP and ADP, ENTPD2 is a focus of cancer-immunology and neuro-oncology research, where its role in the tumor microenvironment and in glioma biology is actively investigated. This unconjugated polyclonal reagent from Antibodies.com was raised in rabbit and supports mapping NTPDase2 distribution in those experimental systems.

Validated for Western blot, immunohistochemistry, and immunofluorescence on human samples, the antibody reflects the established expression pattern of ENTPD2 in nervous-tissue and stromal contexts. Supplied at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol as a preservative system, the 100 µl volume is sized to run multiple staining and blotting experiments.

Store refrigerated and protect from light; the polyclonal format provides epitope diversity useful for following ENTPD2 levels in tissue sections and for confirming protein-level changes after knockdown or inhibitor treatments. Conjugate-free formulation lets researchers pair the antibody with custom secondary labels of their own choice, supporting flexible assay design.